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Previewscombination, it can be further improved
by optimizing the reprogramming envi-
ronment as has been achieved with the
Yamanaka factors in the near future
(Chen et al., 2011).
The realization that reprogramming by
defined factors is a stochastic early and
deterministic late processmay encourage
further efforts to manipulate the ratio
between stochastic and deterministic
phases (Figure 1A). Because reprogram-
ming is a collaboration between the
defined factors and the culture environ-
ment (Li et al., 2010), one may speculate
that ultimately, a ‘‘perfect’’ reprogram-
ming environment may allow reprogram-
ming to proceed with no or very short
stochastic phase (Figure 1A). If so, it
may be feasible to achieve all determin-istic reprogramming with defined factors,
thus, narrowing or reconciling the
difference between SCNT and iPSC
(Figure 1A). As pointed out by the authors,
single cell analysis is at its infancy. Yet,
it has already helped the reprogramming
field so nicely. Much should be antici-
pated from this line of inquiry.
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Ito et al. (2012) recently report inNatureMedicine that fatty acid oxidation (FAO) regulated by PPARd controls
asymmetric division in hematopoietic stem cells (HSCs). This metabolic mechanism prevents HSC exhaus-
tion and is downstream of the promyelocytic leukemia protein PML, suggesting therapeutic implications for
HSC function and disease.Hematopoietic stem cells (HSCs) are
some of the most mysterious entities
of an organism, subdivided into an
incredible variety of subsets. HSCs are
exquisitely sensitive to changes in
transcriptional networks and external
informatory molecules, such as those
provided by the niche microenvironment.
The metabolism of these essentially
quiescent cells has been the focus of
many recent studies (reviewed in Suda
et al., 2011) but the contribution of
lipid metabolism remains unexplored
(Suda et al., 2011). Ito et al. now reportfindings that not only bridge nuclear
organization, transcriptional control, and
lipid metabolism in decisions underlying
asymmetric cell division, but that also
have major implications for therapeutic
manipulation of HSCs.
In a previous study, the Pandolfi group
reported that deletion of pml leads to
loss of HSC quiescence, resulting in
their transient amplification and sub-
sequent exhaustion (Ito et al., 2008).
Here, the authors demonstrate that PML
activates PPARd, a nuclear receptor that
has a key role in stem cell maintenance.Indeed, in multiple in vivo or ex vivo
assays, conditional loss of ppard was
found to decrease HSC abundance and
repopulating ability while treatment with
specific agonists improved HSC function.
Loss of self-renewal likely results from
an increase in HSC cycling, so that loss
of either pml or ppard results in the
accumulation of committed progenitors.
Conversely, defects in pml/ HSCs
were partly rescued by PPARd agonists.
PPARs are central regulators of metabo-
lism and control mitochondrial function,
in particular fatty acid oxidation (FAO).1, October 5, 2012 ª2012 Elsevier Inc. 447
Figure 1. A PML/PPARd/Fatty Acid Oxidation Axis Amenable to Pharmacological
Manipulation at Several Levels Promotes Asymmetric HSC Division
PML nuclear bodies control the acetylation of PCG1A, a critical transcriptional coregulator of PPARs.
PPAR target genes promote fatty acid oxidation (FAO) in the mitochondria. Through uncharacterized
molecular mechanisms, the subsequent metabolic changes promote asymmetric divisions of HSCs,
hence favoring their self-renewal.
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PreviewsIto et al. found that the FAO inhibitor eto-
moxir had a negative effect on long-term
engraftment and repopulating ability in
secondary hosts. Etomoxir not only
induced HSC exhaustion, but also antag-
onized the beneficial effects achieved
by PPAR agonists in terms of improving
HSC function. Activation of this PML/
PPARd/FAO metabolic cascade was
then found to favor HSC asymmetric cell
division, as the authors elegantly demon-
strated with an immunophenotypic
assay using Tie2 and CD48 markers
on mother and daughter cells. Previous
studies had implicated several aspects
of metabolism (in particular hypoxia) in
HSC fate (reviewed in Suda et al., 2011).
This is the first implication of lipid metab-
olism in HSC self-renewal. Importantly,
each of the sequential key steps in this
cascade is amenable to pharmacologic
intervention: PML by interferons and
arsenic, PPARd by existing agonists
available for human use and FAO by
specific inhibitors of the mitochondrial
enzymes responsible for fatty acid
catabolism.
PML organizes nuclear bodies (NBs),
which are known to control a variety of
posttranslational modifications (sumoyla-
tion, phosphorylation, or acetylation) of448 Cell Stem Cell 11, October 5, 2012 ª201the wide range of partner proteins they
recruit (Lallemand-Breitenbach and de
The´, 2010). For instance, PML NBs were
shown to modulate the activity of p53,
Rb, AKT, mTOR, HIF1a, or mitochondrial
regulatory pathways, raising the issue of
whether a common cellular mechanism
underlies these pleiotropic effects. While
PML contributes to p53 regulation,
explaining its prosenescent activities
(Vernier et al., 2011), and is a critical deter-
minant of HSCs or neural stem cell self-
renewal (Ito et al., 2008; Regad et al.,
2009), how it mechanistically modulates
stem cell fate has remained enigmatic.
Interestingly, a recent report from the
Pandolfi group demonstrates that the
same PML/PPARd/FAO pathway in
primary breast cells grown in methyl-
cellulose renders cells resistant to
anoikis, which results in luminal filling in
a 3D basement membrane breast culture
model (Carracedo et al., 2012). In their
breast model, Carracedo et al. find that
recruitment of SIRT1 deacetylase into
PML NBs to greatly decrease PGC1A
acetylation, enhancing its coactivator
function on PPARd signaling and trig-
gering the expression of enzymes
enforcing FAO. Thus, in HSCs, the PML/
PPARd axis promotes HSC self-renewal,2 Elsevier Inc.whereas in the breast model, the same
metabolic switch allows generation of
high levels of ATP from FAO, which pro-
motes cell survival and proliferation. It
may seem paradoxical that the same
PML/PPARd pathway can promote both
the self renewal of normal HSCs through
induction of quiescence and asymmetric
division but also the proliferation of
cancer cells. Future studies should clarify
these issues.
That PML appears to be the upstream
regulator of this key regulatory cascade
raises the issue of its own control.
PML is a stress-induced genewhose tran-
scription is dramatically enhanced by
interferons or p53 activation. The latter
restricts stem cell proliferation and self-
renewal (Cicalese et al., 2009), an activity
that may involve PML. Many of the
proposed functions of PML have been
associated with its ability to form NBs,
at least in part through oxidative stress-
induced PML self-assembly (Jeanne
et al., 2010). The presence of ROS could
therefore potentially activate the PML/
PPARd/FAO axis and in this manner
protect HSCs from ROS, although it
seems equally possible that PML could
also be a ROS scavenger itself. PML
may thus be a stress sensor allowing
HSCs to respond to their environment.
The findings of Ito et al. (2012) open
wide pharmacological perspectives not
only for HSC transplantation, but also
for therapy of hematopoietic malignan-
cies. In addition to stem cell maintenance,
PML promotes leukemia initiating cell
(LIC) self-renewal in bcr-abl leukemic
mice models (Ito et al., 2008). In that
setting, arsenic, which degrades PML,
triggered the progressive loss of LICs,
thus mimicking PML genetic inactivation.
However, apart from acute promyelocytic
leukemia, where arsenic degrades the
driving PML/RARA oncoprotein (Jeanne
et al., 2010), this drug has not yet demon-
strated unambiguous tumor regression in
other malignancies, suggesting that new
therapeutic schemes should be investi-
gated. Interestingly, some previous
studieshave identifiedagents suchas reti-
noids and histone deacetylase inhibitors
(Bug et al., 2005) that could modestly
increaseHSCnumbers, allowing their divi-
sion without forcing their commitment.
These new studies raise the tantalizing
prospect of therapeutic amplification of
HSCs through activation of PML
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Previewsexpression or aggregation, PPARd
signaling, or FAO enhancement (Figure 1).
Clearly, this
will be the focus of intense future studies.
From a basic biology point of view, one
of the most mysterious aspects raised
by this article is how, mechanistically,
the metabolic changes induced by
FAO can directly and immediately con-
trol asymmetric HSC division. It will
also be interesting to study whether
FAO is implicated in the other func-
tions of PML, notably its prosenescence
ones. By directly linking cell metabolism
and stem cell division, these studies
have wide implications in the complex
relationship between metabolism and
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